News | Cardiovascular Ultrasound | January 27, 2016

AMA Assigns New Investigational CPT Code for Myocardial Strain Imaging

Category III code meant to encourage further use of strain imaging in cardiology, cardio-oncology applications

AMA, investigational CPT code, myocardial strain imaging, cardio-oncology

January 27, 2016 — Effective Jan. 1, 2016, the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel assigned a new category III CPT code, 0399T, for use in reporting myocardial strain imaging for the detection of myocardial deformation. While Category III codes generally are not initially reimbursed, they often become payable when they are used routinely in clinical practice.

Research has shown that strain imaging can improve diagnostic assessment, standardize interpretation and assist in improving the monitoring of patients over time to optimize care. Additionally, measurements derived from strain imaging have been shown to be more sensitive and less variable than gold standard measurements like EF, making it increasingly important.

American Society of Echocardiography (ASE) chamber quantification guidelines now recommend strain imaging when assessing function. ASE recommendations for assessment and monitoring with echo of cardio-oncology patients indicate strain imaging should be monitored in this patient population.

The ACVI/ASE/Industry Task Force to Standardize Deformation Imaging issued definitions to improve standardization of 2-D speckle tracking measurements.

Increasingly, studies show that assessing and monitoring strain may improve quality of patient care and reduce costs with patient readmissions.

Although strain imaging has proven to be valuable in the assessment and management of patients with echo, until now, diagnostic software solutions with strain imaging have been research-oriented, laborious and workflow-inefficient in clinical practice.

EchoInsight is among the companies pushing for increased usage of strain imaging to improve diagnostic confidence, standardization and efficiency. Epsilon Imaging’s proprietary speckle tracking technology, TissueTrack, provides robust strain imaging with automation of cardiac functional measurements. It provides clinical strain imaging for improved confidence in assessment and monitoring of wall mechanics for the entire heart. It is available as a stand-alone workstation or client-server architecture using a vendor neutral platform.

For more information: www.epsilon-imaging.com

Related Content

A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020
July 1, 2020 — A 3-D ultrasound
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Diffusion tractography uses the movement of water molecules to identify tracts that connect different parts of the brain. It can be used to pinpoint the part of the thalamus to treat with focused ultrasound. Image courtesy of UT Southwestern Medical Center

Diffusion tractography uses the movement of water molecules to identify tracts that connect different parts of the brain. It can be used to pinpoint the part of the thalamus to treat with focused ultrasound. Image courtesy of UT Southwestern Medical Center

News | Magnetic Resonance Imaging (MRI) | June 15, 2020
June 15, 2020 — Recently developed magneti...
 Samsung announced the immediate availability of the RS85 Prestige, the latest addition to the company’s portfolio of ultrasound systems.
News | Ultrasound Imaging | June 11, 2020
June 11, 2020 — Samsung announced the immediate availability of the ...
Although it is likely that existing ultrasound systems will be repurposed to treat COVID-19 patients, growth is still expected as companies plan to ramp up production. The ultrasound systems market will therefore outpace other diagnostic imaging such as computed tomography (CT) and magnetic resonance imaging (MRI). Leading data and analytics company GlobalData forecasts the market will reach $6bn by 2028, but increased usage due to COVID-19 is anticipated have a tangible effect.
News | Ultrasound Imaging | June 05, 2020
June 5, 2020 — Although it is likely that existing...
The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

News | Coronavirus (COVID-19) | May 26, 2020
May 26, 2020  — Philips Healthcare recently received 510(k) clearance from the U.S.